Abstract:Objective: To explore commonalities and differences in the sociodemographic, health, and neuropsychological characteristics of participants with SCD recruited in two culturally differentiated cohort studies, namely CIMA-Q (Canada; Bellevile et al., 2019) and CompAS (Spain; Juncos et al., 2012). Methods: Older adults with subjective cognitive complaints of the CompAS (N=251; 68.92% women; Control: 30.3%; SCD: 25.9%; MCI: 28.7%) and the CIMA-Q (N=179; 71.5% women; Control:16.1%; SCD: 36.8%; MCI:28.6%) were recruited, respectively, from primary care centers and memory clinics, excluding patients with dementia and other neurological or psychiatric disturbances. Cognitive complaints were assessed considering coincident items of the QAM and MFE questionnaires. Cut-off points for the 5%ile were calculated independently in both samples and according to this, participants were classified as SCD or controls (CompAS: N= 141; CIMA-Q: N=161) considering complaints relevance at baseline (Pereiro et al., 2021). Participants underwent neuropsychological assessment. Participants diagnosed as Mild Cognitive Impairment (MCI) were excluded from the analysis. Between cohort-studies and inter-group (control, SCD) differences were tested in the sociodemographic, health and neuropsychological measures considered. The Holm-Bonferroni correction was applied to reduce the probability of type I error (p<.003). Results: Identical cut-off points for 5%ile were obtained in both samples though SCD prevalence was slightly higher in CIMA-Q. For both samples, equivalence between Control and SCD participants in sociodemographic, health, functionality, and neuropsychological measures was observed. Only complaints and depressive symptomatology was significantly higher in SCD participants than in controls in both CompAS and CIMA-Q studies. Participants of the CIMA-Q, Controls and SCD, showed significantly higher age, cognitive reserve proxies, comorbidity, and better attentional performance than the CompAS participants (see Table 1). CompAS participants, Controls and SCD, showed more neuropsychiatric symptomatology than CIMA-Q participants (see Table 1). Conclusions: Control and SCD participants showed equivalence on sociodemographic, health, functional, and neuropsychological measures in both studies. However, significant between-sample differences in the two groups, particularly in SCD participants, were observed in sociodemographic, health, cognitive reserve, behavioral and attentional measures. Identification of these factors are critical to analyze the transcultural validity of cognitive complaints in predicting progression to AD. Table 1 Between group (control, SCD) and Between study (CIMA-Q, CompAS) differences in sociodemographic, health, and cognitive measures CIMA-Q CompAS Between-studies differences Between-group differences Between-group differences Control SCD Sociodemographics Age NS NS CIMA-Q>CompAS; F(1,124)=22.78; p<.001 CIMA-Q>CompAS; F(1,172)=36.97; p<.001 Gender NS NS NS NS Schooling (years) NS NS NS CIMA-Q>CompAS; F(1,172)=20.74; p<.001 Prof. qualification NS NS CIMA-Q>CompAS; χ 2 4 =18.18; p=001 CIMA-Q>CompAS; χ 2 4 =33.95; p<001 Cognitive reserve (quartiles) NS NS CIMA-Q>CompAS; χ 2 3 =13.57; p=004 CIMA-Q>CompAS;χ 2 3 ==42.56; p<001 Memory familiar antecedents NS NS NS CIMA-Q>CompAS; χ 2 1 ==15.03; p<001 Neuropsychology Subjective complaints* SCD>Control; F(1,119)=147.17, p<.001) SCD>Control; F(1,177)=192.87, p<.001 NS NS Charlson Index* SCD>Control; F(1,115)=5.29, p=.023 NS CIMA-Q>CompAS; F(1,123)=394.96; p<.001 CIMA-Q>CompAS; F(1,168)=335.98; p<.001 General cognition NS (MoCA) NS (CAMCOG-R) -- -- GDS-15* SCD>Control; F(1,119)=8.60, p=.004 SCD>Control; F(1,176)=11.97, p<.001 NS NS TMT-A (secs.)* NS NS NS NS TMT-B (secs.)* NS NS CompAS>CIMA-Q; F(1,118)=12.56; p<.001 CompAS>CIMA-Q; F(1,163)=21.74; p<.001 Verbal fluency NS NS NS NS Semantic fluency N -Abstract Truncated-

Mild Cognitive Impairment or Attention-Deficit/Hyperactivity Disorder in Older Adults? A Cross Sectional Study

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

ADHD in Older Adults: Diagnostic Confusion and Treatment Hesitancy

Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements

Characteristic Neurocognitive Profile Associated with Adult Attention-Deficit/hyperactivity Disorder.

P3-459: Neuropsychiatric Features in Alzheimer's Disease and Mild Cognitive Impairment in Memory Clinic

Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: a 10/66 Population-Based Study.

Cognitive functioning in adult psychiatric patients with and without attention‐deficit/hyperactivity disorder

Neuropsychological Deficits in Adult ADHD: Evidence for Differential Attentional Impairments, Deficient Executive Functions, and High Self-Reported Functional Impairments

Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain

Incidence of Mild Cognitive Impairment and Alzheimer Disease in Southern Brazil

Neuropsychological functioning of individuals at clinical evaluation of adult ADHD

The importance of including ADHD in the differential diagnosis in adults. About a case

P153: The CIMA-Q and CompAS cohort studies on factors associated with Alzheimer's disease (AD): Exploring sociodemographic, health and neuropsychological profile of Subjective Cognitive Decline (SCD) participants from two culturally differentiated samples.

The Clinical Manifestation, Executive Dysfunction, and Caregiver Strain in Subthreshold Attention-Deficit/Hyperactivity Disorder.

Neurocognitive Features of Mild Cognitive Impairment and Distress Symptoms in Older Adults Without Major Depression

Heterogeneity of Cognition in Older Adults with Remitted Major Depressive Disorder: A Latent Profile Analysis

P152: Early detection and evolution of Mild Behavioral Impairment in a sample of people with subjective cognitive complaints

The association of the 24-hour activity cycle profiles with cognition in older adults with mild cognitive impairment: A cross-sectional study

Mild Cognitive Impairment Screening in Older Adults With Type 2 DM

Altered Executive Function in Pre-Mild Cognitive Impairment